2092 Myocardial field distortions during first pass of a gadolinium based contrast agent in perfusion studies

Bibliographic Details
Published in:	Journal of Cardiovascular Magnetic Resonance
Main Authors:	Wage Ricardo, Bucciarelli-Ducci Chiara, Firmin David, Gatehouse Peter, Ferreira Pedro
Format:	Article
Language:	English
Published:	Elsevier 2008-10-01

Similar Items

Variability of myocardial perfusion dark rim Gibbs artifacts due to sub-pixel shifts
by: Kellman Peter, et al.
Published: (2009-05-01)

Variability of perfusion dark rim artifacts due to Gibbs ringing
by: Bucciarelli-Ducci Chiara, et al.
Published: (2009-01-01)

Myocardial first-pass perfusion imaging with hybrid-EPI: frequency-offsets and potential artefacts
by: Ferreira Pedro F, et al.
Published: (2012-06-01)

Diagnostic accuracy of half-contrast dose bSSFP vs full-contrast dose hEPI MR perfusion imaging in patients with known or suspected coronary artery disease
by: Prasad Sanjay, et al.
Published: (2009-01-01)

2092
by: Shaun Evan Gruenbaum, et al.
Published: (2017-09-01)

2056 Quantitative magnetic resonance first-pass perfusion analysis in hypertrophic cardiomyopathy. Intrastudy variability
by: Pennell Dudley J, et al.
Published: (2008-10-01)

226 Myocardial fibrosis, wall thickness, and microvascular perfusion in hypertrophic cardiomyopathy. a cardiovascular magnetic resonance study
by: O'Hanlon Rory, et al.
Published: (2008-10-01)

Myocardial Perfusion Imaging artifacts: centric h-EPI and its sensitivity to frequency errors
by: Firmin David, et al.
Published: (2010-01-01)

Myocardial perfusion with ultra fast spin-echo single-shot echo-planar-imaging
by: Firmin David, et al.
Published: (2010-01-01)

Dynamic TI for late gadolinium enhancement imaging in atrial fibrillation
by: Keegan Jennifer, et al.
Published: (2012-02-01)

In-vivo distortion of through-plane flow by spiral phase-contrast imaging
by: Pierce Iain T, et al.
Published: (2012-02-01)

2015 Myocardial perfusion after percutaneous recanalization of coronary chronic total occlusions: a cardiovascular magnetic resonance study
by: Prasad Sanjay K, et al.
Published: (2008-10-01)

Diagnostic performance of perfusion cardiovascular magnetic resonance compared with gated myocardial perfusion spect in patients with known or suspected coronary artery disease
by: Prasad Sanjay, et al.
Published: (2010-01-01)

Rapid assessment of myocardial scar and viability in ischemic heart disease: a cardiovascular magnetic resonance study
by: Wage Rick, et al.
Published: (2009-01-01)

Quantitative Perfusion Analysis of First-Pass Contrast Enhancement Kinetics: Application to MRI of Myocardial Perfusion in Coronary Artery Disease.
by: Sohae Chung, et al.
Published: (2016-01-01)

Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction
by: Redwood Simon, et al.
Published: (2009-08-01)

In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates
by: Ben Wang, et al.
Published: (2018-07-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Early gadolinium enhancement for the detection of myocardial oedema (EGE vs T2-STIR vs ACUT2E): a new method to assess the area at risk?
by: McAlindon Elisa, et al.
Published: (2012-02-01)

Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents
by: Nevzat Karabulut
Published: (2015-07-01)

Late gadolinium enhancement imaging using spiral readouts at 3T
by: Pierce Iain, et al.
Published: (2013-01-01)

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance
by: Bergvall Erik, et al.
Published: (2010-11-01)

Diagnosis of Paracardiac Castleman Disease by Dynamic Gadolinium-Enhanced First Pass Perfusion Magnetic Resonance Imaging
by: Andrew Crean, et al.
Published: (2008-01-01)

Myocardial perfusion and viability after percutaneous recanalization of coronary chronic total occlusions: a cardiovascular magnetic resonance study
by: Gatehouse Peter, et al.
Published: (2009-01-01)

Steady-state first-pass perfusion (SSFPP): A 3D TWIST in myocardial first-pass perfusion imaging
by: Giri Shivraman, et al.
Published: (2012-02-01)

Dynamic simulation of first pass myocardial perfusion MR with a novel perfusion phantom
by: Schaeffter Tobias, et al.
Published: (2011-02-01)

Reproducibility of First Pass Perfusion CMR at rest and during hyperaemia for estimation of myocardial perfusion
by: Biglands John, et al.
Published: (2010-01-01)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
by: Cyprian Olchowy, et al.
Published: (2017-01-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
by: Atiya Fatima, et al.
Published: (2021-09-01)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
by: Kim Hyo Jeong, et al.
Published: (2010-01-01)

Frequency of Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
by: Heera Yang, et al.
Published: (2022-08-01)

Impact of gadolinium-based MRI contrast agent and local anesthetics co-administration on chondrogenic gadolinium uptake and cytotoxicity
by: Alexander Zimmerer, et al.
Published: (2024-04-01)

Manganese-Based Contrast Agents as Alternatives to Gadolinium: A Comprehensive Review
by: Linda Poggiarelli, et al.
Published: (2025-07-01)

Electrochemical Method for the Design of New Possible Gadolinium-Based Contrast Agents
by: Claudia Carbone, et al.
Published: (2024-12-01)

Biomedical Applications of Gadolinium‐Containing Biomaterials: Not Only MRI Contrast Agent
by: Xingtong Pan, et al.
Published: (2025-05-01)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
by: Ryan P. Sabotin, et al.
Published: (2023-10-01)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
by: Bugra Kerget, et al.
Published: (2018-01-01)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
by: Charmainne Cruje, et al.
Published: (2021-08-01)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
by: Nathalie Ackermans, et al.
Published: (2019-01-01)

235 Simultaneous myocardial first-pass perfusion and strain imaging with DENSE
by: Lorenz Christine H, et al.
Published: (2008-10-01)